Fundraising Fox
🦊/People
Sign in

Henry Chen

Investor

Managing Partner at Delos Capital · Board director at Averna Therapeutics · Board director at Curamir Therapeutics · Board director at Tulavi Therapeutics

Hong Kong

Find your path to Henry

1,311 people in our graph share verified history with Henry — schools, employers, funds. One of them is your warm intro.

Adam ValkinunlockedHenry: together at Harvard University (1992–1993)
×9Henry: together at Goldman Sachs
Henry: together at Harvard University
Henry: together at Permira

About

Henry Chen founded Delos Capital in 2014 and serves as its Managing Partner. He was previously a Partner and Co-Head of Asia at Permira, and earlier spent nine years at Goldman Sachs as a Managing Director and co-head of the General Industrials Group for Asia (ex-Japan), following corporate finance law work at Davis Polk. He has co-founded Curamir Therapeutics and Tulavi Therapeutics and served as CEO and Chairman of Tanvex BioPharma, and holds bachelor's and master's degrees from Harvard University and a JD from Harvard Law School.

Contact· self-published, not guessed

Board director at Averna Therapeutics

Intro paths

→

In turn, Henry can intro founders to Averna Therapeutics's investors below.

Averna Therapeutics's investors · 4

Deep InsightTel AvivDelos CapitalCambridgeNovartis Venture FundBasel · $5M – $25M checks · since 2024OrbiMedNew York · $1M – $75M checks · since 2024

Board director at Curamir Therapeutics

Intro paths

→

In turn, Henry can intro founders to Curamir Therapeutics's investors below.

Curamir Therapeutics's investors · 1

Delos CapitalCambridge · since 2019

Co-founders at Curamir Therapeutics

LB
LAN BO CHENExecutive Officer, Director

Board director at Tulavi Therapeutics

Intro paths

→

In turn, Henry can intro founders to Tulavi Therapeutics's investors below.

Tulavi Therapeutics's investors · 2

Ascension VenturesSaint Louis · $10M – $20M checksDelos CapitalCambridge

Co-founders at Tulavi Therapeutics

FK
Farhad KhosraviExecutive Officer, Director
FKFred Khosravi
Fred KhosraviChairman & Co-Founder

Experience

  1. Delos CapitalFounder and Managing Partnercurrent2014 — present
  2. Tanvex Biopharma USA, IncChairperson2023 — 2025
  3. Tanvex Biopharma USA, IncChief Executive Officer2023 — 2024
  4. Curamir Therapeutics, Inc.Chief Executive Officer2019 — 2022Woburn, Massachusetts, United States
  5. Tanvex Biopharma USA, IncChief Executive Officer2020 — 2021
  6. Tanvex Biopharma USA, IncChief Financial Officer2020 — 2021
  7. Tanvex Biopharma USA, IncChairman2021
  8. PermiraPartner, Co-head, Asia2008 — 2014Hong Kong
  9. Goldman SachsManaging Director1999 — 2008Hong Kong
  10. Davis Polk & Wardwell LLPAssociate1996 — 1999

Skills & more

Strategy1Corporate Development6Private Equity15Venture Capital16Mergers & Acquisitions7Valuation3Due Diligence4Emerging Markets2M&A experience1LBO1Capital Markets1Investment Banking6
+2 moreBusiness StrategyInvestments

From Henry's professional profile.

Investments

Board seats

Tanvex BioPharma Inc.

Investor

Curamir Therapeutics Inc.Tulavi Therapeutics

Per the firm's website.

Colleagues at Delos Capital

Adolfo Pena
Director at Delos Capital
Agnes Kwok
Financial Controller at Delos Capital
Andrea Lok
Executive Assistant at Delos Capital
Carrie Greenaway
Office Manager at Delos Capital
Dawn Griffiths
Director at Delos Capital
Eric Huang
Partner at Delos Capital
Faris Lodin
Managing Director at Sterling Equity
Hank Huang
Associate at Delos Capital

Frequently asked questions

Who is Henry Chen?
Henry Chen founded Delos Capital in 2014 and serves as its Managing Partner. He was previously a Partner and Co-Head of Asia at Permira, and earlier spent nine years at Goldman Sachs as a Managing Director and co-head of the General Industrials Group for Asia (ex-Japan), following corporate finance law work at Davis Polk. He has co-founded Curamir Therapeutics and Tulavi Therapeutics and served as CEO and Chairman of Tanvex BioPharma, and holds bachelor's and master's degrees from Harvard University and a JD from Harvard Law School.
Where does Henry Chen work?
Henry Chen is Managing Partner at Delos Capital and Board director at Averna Therapeutics and Board director at Curamir Therapeutics and Board director at Tulavi Therapeutics.
What boards does Henry Chen sit on?
Henry Chen holds tracked board seats at Tanvex BioPharma Inc..
What companies has Henry Chen invested in?
Investments tracked here include Curamir Therapeutics Inc., Tulavi Therapeutics.
Where did Henry Chen go to school?
Henry Chen studied at Harvard Law School (JD); Harvard University (Master of Arts (M.A.), History of Science); Harvard University (AB, History and Science).

Same school

Shared employers